Change Requests

Key Information

Previous ICR	202205-1557-008

Federal Register Notices

Authorizing Statutes

Abstract

Regulation C, which implements the Home Mortgage Disclosure Act (HMDA) enacted in 1975, requires certain depository and non-depository institutions that make certain mortgage loans to collect, report, and disclose data about originations and purchases of mortgage loans, as well as loan applications that do not result in originations. HMDA generates loan data that can be used to: (1) help determine whether financial institutions are serving the housing needs of their communities; (2) assist public officials in distributing public-sector investments so as to attract private investment to areas where it is needed; and (3) assist in identifying possible discriminatory lending patterns and enforcing anti-discrimination statutes. The Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (the Dodd-Frank Act) transferred HMDA and its rulemaking authority from the Board of Governors of the Federal Reserve System (Board) to the Consumer Financial Protection Bureau (CFPB) and transferred supervisory and enforcement authority for HMDA for depository institutions over $10 billion in consolidated assets from the Board, Federal Deposit Insurance Corporation, OCC, and National Credit Union Administration to the CFPB. The CFPB published a final rule on October 28, 2015, that expanded the data collected and reported under HMDA, as implemented by Regulation C, and published a final rule on September 13, 2017, with additional corrections and clarifications (final rules). The final rules also modified the types of lenders and loans covered under Regulation C. First, for data collected in 2017, and reported in 2018, the rule simply reduces the number of institutions covered under Regulation C because only depositories originating more than 25 closed end loans must report. Then, starting January 1, 2018, an institution was required to begin collecting expanded data under HMDA if it either originates 25 or more closed end mortgage loans or 500 or more open-end lines of credit secured by a dwelling in each of the two preceding years, in addition to meeting other criteria. These institutions will begin reporting the expanded HMDA data in 2019. Starting in 2020, an institution will collect data on open-end lines of credit if it originates more than 100 open-end lines of credit secured by a dwelling in each of the two preceding years (and report that open-end lines of credit data beginning in 2021). An institution also will collect and report covered loans and applications quarterly if it received a total of at least 60,000 covered loans and applications in the preceding calendar year. An institution must report a covered loan if it has met the loan origination threshold for that loan category (open end or closed-end); an institution that is not required to report data may voluntarily do so. In addition, the types of loans covered under Regulation C changed under the final rules beginning in 2018. Covered institutions are required to collect and report any mortgage loan secured by a dwelling, including open end lines of credit, regardless of the loan’s purpose. Dwelling secured loans that are made principally for a commercial or business purpose, as well as agricultural–purpose loans and other specified loans are excluded. On September 7, 2018, the CFPB issued an interpretive and procedural rule to implement section 104(a) of the Economic Growth, Regulatory Relief, and Consumer Protection Act (EGRRCPA). Section 104(a) amended certain provisions of the Home Mortgage Disclosure Act (HMDA) by adding partial exemptions from HMDA's requirements for certain insured depository institutions and insured credit unions. Insured depository institutions and insured credit unions covered by a partial exemption have the option of reporting exempt data fields as long as they report all data fields within any exempt data point for which they report data.

Key Information

Previous ICR	202204-0551-001

Federal Register Notices

Authorizing Statutes

Abstract

Section 12315 of the Agricultural Act of 2014 established the "Agriculture Wool Apparel Manufacturers Trust Fund" to be used for the purpose of reducing the injury to domestic manufacturers resulting from tariffs on wool fabric that are higher than tariffs on certain apparel articles made of wool fabric. Claimants must submit an affidavit certifying that they meet the eligibility requirements for each program they wish to apply for an annual payment.

Key Information

Previous ICR	202209-0906-002

Federal Register Notices

Authorizing Statutes

Abstract

The Health Resources and Services Administration (HRSA) seeks to collect data through the Scholarships for Disadvantaged Students (SDS) Program Specific Form. This data collection is essential for HRSA to advance its mission and close critical data gaps in program performance and long-term sustainability. The information will be collected from institutions that apply for SDS program awards. HRSA will use this information to: • Assess applicants' experience, need, and performance in strengthening the health workforce • Evaluate service and progress in serving target populations • Help grant reviewers and policymakers make informed decisions • Determine eligibility for the SDS program

Key Information

Previous ICR	202501-0938-015

Federal Register Notices

Authorizing Statutes

Abstract

Section 10201(i) of the Affordable Care Act (ACA) added provisions under Section 1115 of the Social Security Act to require the Secretary to publish no later than 180 days after the enactment of this act, regulations that establish application requirements for demonstration projects. Under section 10201(i) of ACA the Secretary must establish a process for public notice and comment at the State level, and at the federal level after an application for a demonstration project is received by the Secretary. In addition, the Secretary must implement reporting requirements for States, establish a process for the periodic evaluation of demonstration projects and report annually to Congress on the implementation of previously approved demonstration projects. This collection would address the provisions required under Sections 10201(i) of the Affordable Care Act.

Key Information

Previous ICR	202311-1205-001

Federal Register Notices

Authorizing Statutes

Abstract

The O*NET Data Collection Program is an ongoing effort to collect and maintain current information on the detailed characteristics of occupations and skills for more than 900 occupations. The resulting database provides the most comprehensive standardized source of occupational and skills information in the nation. O*NET information is used by a wide range of audiences, including individuals making career decisions, public agencies and schools providing career exploration services or education and training programs, and businesses making staffing and training decisions. The O*NET system provides a common language, framework and database to meet the administrative needs of various federal programs, including workforce investment and training programs supported by funding from the Departments of Labor, Education, and Health and Human Services.

Key Information

Previous ICR	202301-7100-003

Federal Register Notices

Authorizing Statutes

Abstract

This information collection comprises the following reports: • Debit Card Issuer Survey (FR 3064a) collects data from issuers of debit cards (including general-use prepaid cards) that, together with their affiliates, have assets of $10 billion or more, including information regarding the volume and value of debit card transactions; chargebacks and returns; costs of authorization, clearance, and settlement of debit card transactions; other costs incurred in connection with particular debit card transactions; fraud prevention costs and fraud losses; and interchange fee revenue. • Payment Card Network Survey (FR 3064b) collects data from payment card networks, including the volume and value of debit card transactions; interchange fees; network fees; and payments and incentives paid by networks to acquirers, merchants, and issuers. The data from the FR 3064a and FR 3064b are used to fulfill a statutory requirement that the Board disclose certain information regarding debit card transactions on a biennial basis.3 In addition, the Board uses data from the Payment Card Network Survey (FR 3064b) to publicly report on an annual basis the extent to which networks have established separate interchange fees for exempt and covered issuers.

Key Information

Previous ICR	202210-2900-010

Federal Register Notices

Authorizing Statutes

Abstract

VAAR clause 852.237–70, Indemnification and Medical Liability Insurance, is used in lieu of Federal Acquisition Regulation (FAR) clause 52.237–7, Indemnification and Medical Liability Insurance, in solicitations and contracts for the acquisition of nonpersonal health care services. It requires the apparent successful bidder/offeror, upon the request of the contracting officer, prior to contract award, to furnish evidence of insurability of the offeror and/or all health-care providers who will perform under the contract. In addition, the clause requires the contractor, prior to commencement of services under the contract, to provide Certificates of Insurance or insurance policies evidencing that the firm possesses the types and amounts of insurance required by the solicitation. The information is required in order to protect VA by ensuring that the firm to which award may be made and the individuals who may provide health care services under the contract are insurable and that, following award, the contractor and its employees will continue to possess the types and amounts of insurance required by the solicitation. It helps ensure that VA will not be held liable for any negligent acts of the contractor or its employees and ensures that VA and VA beneficiaries are protected by adequate insurance coverage. VAAR clause 852.228–71, Indemnification and Insurance, is used in solicitations for vehicle or aircraft services. It requires the apparent successful bidder/offeror, prior to contract award, to furnish evidence that the firm possesses the types and amounts of insurance required by the solicitation. This evidence is in the form of a certificate from the firm’s insurance company. The information is required to protect VA by ensuring that the firm to which award will be made possesses the types and amounts of insurance required by the solicitation. It helps ensure that VA will not be held liable for any negligent acts of the contractor and ensures that VA beneficiaries and the public are protected by adequate insurance coverage. VA uses the information to determine whether additional contract terms and conditions are necessary. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. The Federal Register notice with a 60-day comment period soliciting comments on this collection of information was published at 90 FR 39264, August 14, 2025.

Key Information

Previous ICR	202301-0915-004

Federal Register Notices

Authorizing Statutes

Abstract

RWHAP ADAP is a state and territory-administered program that provides Food and Drug Administration-approved medications to low-income people with HIV who have limited or no health coverage from private insurance, Medicaid, or Medicare. RWHAP ADAP funds may also be used to purchase health care coverage for eligible clients and for services that enhance access, adherence, and monitoring of drug treatments. RWHAP Part B reporting requirements include the annual submission of an ADAP Data Report (ADR), including a Recipient Report and a Client Report. The Recipient Report is a collection of basic information about grant recipient characteristics and policies including program administration, purchasing mechanisms, funding, and expenditures. The Client Report is a collection of client-level records (one record for each client enrolled in the RWHAP ADAP), which includes the client’s encrypted unique identifier, basic demographic data, enrollment information, services received, and clinical data.

Key Information

Previous ICR	202310-0938-004

Federal Register Notices

Authorizing Statutes

Abstract

CMS is performing a "Survey of Retail Prices: Payment and Utilization Rates, and Performance Rankings." This study is divided into two parts. Part I focuses on the retail community pharmacy consumer prices. It also includes reporting by the States of payment and utilization rates for the 50 most widely prescribed drugs, and comparing State drug payment rates with the national retail survey prices. The template for States to use to complete (Effective July 1, 2013, CMS has suspended Part I of the nationwide retail survey for collecting information about consumer purchase prices, pending funding decisions.) Part II of this contract focuses on the retail community pharmacy ingredient costs. This segment provides for a survey of the average acquisition costs of all covered outpatient drugs purchased by retail community pharmacies. The prices will be updated on at least a monthly basis.

Key Information

Previous ICR	202401-0945-001

Federal Register Notices

Authorizing Statutes

Abstract

The Confidentiality of Substance Use Disorder Patient Records regulations (42 CFR part 2) implement section 543 of the Public Health Service Act, 42 United States Code (U.S.C.) § 290dd-2, as amended by section 131 of the Alcohol, Drug Abuse and Mental Health Administration Reorganization Act (ADAMHA Reorganization Act), Pub. L., 102-321 (July 10, 1992) and section 3221 of the Coronavirus Aid, Relief, and Economic Security Act (CARES Act), Public Law 116-136 (March 27, 2020). The regulations serve to protect the confidentiality of patient records created by federally funded programs for the treatment of substance use disorder. The Department of Health and Human Services has published regulatory changes to implement the CARES Act.

Key Information

Previous ICR	202401-0945-002

Federal Register Notices

Authorizing Statutes

Abstract

The individually identifiable health information collected is used by patients and by more than 700,000 covered entities affected by the HIPAA Privacy Rule. The information is routinely used by covered entities for treatment, payment, and health care operations. In addition, the information is used for specified public policy purposes, including research, public health, and as required by other laws.

Key Information

Previous ICR	202311-0930-002

Federal Register Notices

Authorizing Statutes

Abstract

The information collected through the four stages of the cross-site evaluation of the GLS Suicide Prevention and Early Intervention Programs will describe for State/Tribal grantees (1) the context in which suicide prevention activities are being implemented, (2) the products and services funded through the program, (3) the training experiences of individuals who receive training as part of the suicide prevention programs, (4) the utilization and penetration of the skills, knowledge and techniques learned through suicide prevention training programs, and (5) the referral networks in place to support youth identified at risk for suicide.

Key Information

Previous ICR	202507-0920-008

Federal Register Notices

Authorizing Statutes

Abstract

The Centers for Disease Control and Prevention (CDC) uses Fellowship Management System (FMS) to collect, process, and manage data from nonfederal applicants seeking training or public health support services through CDC fellowships. FMS is used to electronically submit fellowship applications, submit fellowship host site proposals, track fellows’ activities during their fellowships, and maintain fellowship alumni directories online. FMS is a key tool in CDC’s efforts to maintain and develop a robust public health workforce. This Non-Substantive Change Request is submitted to modify the content of two modules of the electronic Fellowship Management System (FMS). There is no change anticipated to the currently approved burden.

Key Information

Previous ICR	202108-0938-002

Federal Register Notices

Authorizing Statutes

Abstract

Generally, under the Inpatient Prospective Payment System (IPPS), Medicare payment to the hospital varies based on hospital-specific and patient-specific characteristics. Each Medicare claim for inpatient services is classified into the applicable Medicare Severity Diagnosis-Related Group (MS-DRG) for payment based on certain patient-specific elements, including the principal diagnosis, additional or secondary diagnoses, and procedures reported on the claim. The MS– DRG classification system currently has 337 base DRGs, most of which are split into 2 or 3 MS– DRGs based on the presence of either a complication or comorbidity (CC) or major complication or comorbidity (MCC), resulting in a total of 767 MS-DRGs for FY 2021. Effective October 1, 2015, providers use the International Classification of Diseases, 10th Revision, Clinical Modification (ICD–10–CM) diagnosis code set in all healthcare settings and the International Classification of Diseases, 10th Revision, Procedure Coding System (ICD–10– PCS) is the code set used for inpatient hospital procedure coding. These diagnosis and procedure codes are mapped or “grouped” to specific MS-DRGs for payment under the IPPS using the ICD-10 MS-DRG Grouper software. The public may submit requests to create a new MS-DRG(s), modify an existing MS-DRG(s), change the severity level designation for a diagnosis code(s), change the operating room (O.R.) designation of a procedure code(s), reassign diagnosis and/or procedure codes among Major Diagnostic Categories (MDCs), modify the Medicare Code Editor (MCE), or modify the surgical hierarchy. We examine these requests using statistical analysis and the judgment of our clinical advisors to evaluate the requested changes and consider any proposed updates to the MS-DRGs. Interested parties can include any information they choose to support a MS-DRG change request.

Key Information

Previous ICR	202508-1240-001

Federal Register Notices

Authorizing Statutes

Abstract

The CM-910 is used to obtain information about prospective representative payees to determine whether they are qualified to handle monetary benefits on behalf of a beneficiary under Part 901 of the Black Lung Benefits Act.

Key Information

Previous ICR	202202-0910-010

Federal Register Notices

Authorizing Statutes

Abstract

This ICR collects information from certain drug and biologic manufacturers who are subject to Prescription Drug User fees. These fees are related to the submission of certain new drug and biologics license applications as well as for certain approved annual program fees. In addition, the ICR collects information relating to the submission of requests for waivers, exemptions, reductions, or for refunds of these user fees. Manufacturers submit information in accordance with established statutory authorities. Form FDA 3397, Prescription Drug User Fee Cover Sheet, and Form FDA 3971, Small Business Waivers and Refund Requests, were developed to assist respondents with submission of required information.

Key Information

Previous ICR	202310-0910-004

Federal Register Notices

Authorizing Statutes

Abstract

This information collection supports FDA's User Fee program with regard to Generic Drugs. Form FDA 3794, the Generic Drug User Fee Cover Sheet, requests the minimum information necessary from applicants to enable us to determine the total amount of generic drug user fees required, and to account for and track user fees. Generic drug application holders and API and/or FDF facility’s owner will fill out the cover sheet to accompany payment. Although applicants and manufacturers may choose among several methods of payments, all applicants must create and/or submit all GDUFA Cover Sheets by using the FDA’s web-based electronic User Fee System.

Key Information

Previous ICR	202205-3235-004

Federal Register Notices

Authorizing Statutes

Abstract

Under Section 15B(a) of the Exchange Act (15 U.S.C. 78o-4(a)), municipal securities dealers which are banks, or separately identifiable departments or divisions of banks (collectively, “bank municipal securities dealers”) are required to be registered with the Commission in accordance with such rules as the Commission may prescribe as necessary or appropriate in the public interest or for the protection of investors. Under Section 15B(c) of the Exchange Act (15 U.S.C. 78o-4(c)), any registered municipal securities dealer may, upon such terms and conditions as the Commission may deem necessary in the public interest or for the protection of investors, withdraw from registration by filing a written notice of withdrawal with the Commission. Rule 15Ba2-1 (17 CFR 240.15Ba2-1) provides that an application for registration by a bank municipal securities dealer must be filed on Form MSD (17 CFR 249.1100). Rule 15Ba2-1 further provides that if the information contained in any application for registration on Form MSD, or in any amendment to such application, is or becomes inaccurate for any reason, the applicant must promptly file an amendment on Form MSD correcting such information. Rule 15Ba2-4 (17 CFR 240.15Ba2-4) permits the successor to a registered municipal securities dealer to assume immediate responsibility for the operation of the predecessor’s business provided certain requirements are met, including the filing of a successor application on Form MSD. Rule 15Bc3-1 (17 CFR 240.15Bc3-1) provides that bank municipal securities dealers that wish to withdraw from registration must file a notice of withdrawal from registration on Form MSDW (17 CFR 249.1110). Rule 15Bc3-1 further provides that, prior to filing a notice of withdrawal from registration on Form MSDW, a bank municipal securities dealer must amend Form MSD in accordance with Rule 15Ba2-1(b) to update any inaccurate information. Rule 15Ba2-5 (17 CFR 240.15Ba2-5) permits a duly appointed (or duly qualified) fiduciary to assume immediate responsibility for the operation of a registered municipal securities dealer’s business. Under the rule, the registration of a municipal securities dealer is deemed to be the registration of any fiduciary, appointed or qualified by order, judgment, or decree of a court of competent jurisdiction to continue the business of such municipal securities dealer, provided that such fiduciary files with the Commission, within 30 days after entering upon the performance of his duties, a statement setting forth as to such fiduciary substantially the same information required by Form MSD or Form BD (“Rule 15Ba2-5 Statement”). The Commission uses the information obtained from Form MSD, Form MSDW, and Rule 15Ba2-5 Statement filings to, among other things, determine whether bank municipal securities dealers, their Rule 15Ba2-4 successors, and their Rule 15Ba2-5 fiduciaries meet the standards for registration set forth in the Exchange Act, and whether it is in the public interest to permit a bank municipal securities dealer to withdraw its registration. Certain provisions of Rule 15Ba2-4 and Rule 15Bc3-1 apply to non-bank municipal securities dealers which make registration filings on the standard forms for brokers and dealers (Form BD instead of Form MSD, and Form BDW instead of Form MSDW). Burden estimates for such non-bank municipal securities dealers are accounted for in the Supporting Statements for Form BD (OMB Control No. 3235-0012) and Form BDW (OMB Control No. 3235-0018) and are not included herein.

Key Information

Federal Register Notices

Abstract

Applicants seeking remission of financial penalties by the President will be asked to respond to this collection. The principal purpose for collecting this information is to enable the Office of the Pardon Attorney to process applicants' requests for remission of financial penalties. The information is necessary to verify applicants' identities, conduct investigation of the applicants' backgrounds, criminal records, and conduct since their conviction, and to provide notice to the Federal Bureau of Investigation, U.S. Attorneys' Offices, U.S. Probation Offices, and federal courts in the event of grants of executive clemency

Key Information

Previous ICR	202307-1140-005

Federal Register Notices

Authorizing Statutes

Abstract

Persons with an NFA firearm must apply to ATF for approval to transfer and register the firearm as required by the NFA (26 USC 5812). ATF Form 5320.4 ("Form 4"), is the prescribed means for submitting this application, facilitates and records the firearms transfer, and also serves as proof of registration once approved.

Key Information

Previous ICR	202208-1140-007

Federal Register Notices

Authorizing Statutes

Abstract

Any person other than a qualified manufacturer who wishes to make and register an NFA firearm must submit a written application to ATF on a form prescribed by ATF. 26 U.S.C. § 5822. They must also identify the firearm they are making, themself as the maker, and, if an individual, must include their fingerprints and a photograph with the application. In § 479.62, ATF prescribed Form 1 (ATF form number 5320.1), Application to Make and Register a Firearm for these required purposes.

Key Information

Previous ICR	202507-0910-009

Federal Register Notices

Authorizing Statutes

Abstract

This information collection supports continued implementation of Food and Drug Administration regulations governing applications for FDA approval to market a new drug. Respondents to the collection are individuals or entities submitting such applications to the agency in accordance with applicable statutory and regulatory provisions, and commitments established with industry in accordance with user fee performance goals.

Key Information

Previous ICR	202511-1140-002

Federal Register Notices

Authorizing Statutes

Abstract

Persons with an NFA firearm must apply to ATF for approval to transfer and register the firearm as required by the NFA (26 USC 5812). ATF Form 5320.4 ("Form 4"), is the prescribed means for submitting this application, facilitates and records the firearms transfer, and also serves as proof of registration once approved.

Key Information

Previous ICR	202511-1140-003

Federal Register Notices

Authorizing Statutes

Abstract

Any person other than a qualified manufacturer who wishes to make and register an NFA firearm must submit a written application to ATF on a form prescribed by ATF. 26 U.S.C. § 5822. They must also identify the firearm they are making, themself as the maker, and, if an individual, must include their fingerprints and a photograph with the application. In § 479.62, ATF prescribed Form 1 (ATF form number 5320.1), Application to Make and Register a Firearm for these required purposes.

Key Information

Previous ICR	202404-1240-007

Federal Register Notices

Authorizing Statutes

Abstract

Form OWCP-915 is used to claim reimbursement for out-of-pocket covered medical expenses paid by a beneficiary, and must be accompanied by required billing data elements (prepared by the medical provider) and by proof of payment by the beneficiary.